论文部分内容阅读
１９８６年１月～１９９０年１２月用单纯放疗和合并化疗治疗２２４例鼻咽癌患者。３年生存率分别为８６％和８７．８％（Ｐ＞０．０５），５年生存率为５９％和７２．７的（Ｐ＜０．０５）。放疗合并化疗组原发灶和转移灶退缩均优于单纯放疗组，远处转移减少。化疗药物能提高肿瘤的放疗敏感性，放疗合并化疗是提高鼻咽癌患者生存率的重要途径。
January 1986 ~ December 1990 with radiotherapy alone and combined chemotherapy of 224 cases of nasopharyngeal carcinoma patients. The 3-year survival rates were 86% and 87.8% respectively (P> 0.05), and the 5-year survival rates were 59% and 72.7 (P <0.05). Radiotherapy combined with chemotherapy group of primary and metastatic lesions were better than radiotherapy alone group, distant metastasis decreased. Chemotherapy drugs can improve the radiosensitivity of the tumor, radiotherapy combined with chemotherapy is an important way to improve the survival rate of patients with nasopharyngeal carcinoma.